The dosimetry market is valued at USD 3.28 billion in 2025 and is slated to exhibit USD 5.1 billion by 2035, which shows a ...

The research team tested the therapy in a small group of 18 patients with recurrent glioblastoma in a phase 1 clinical trial, which primarily examines the treatment’s safety profile. Related Content.

Prompt Health, the AI-powered clinic operations platform built for rehab therapy, today announced its acquisition of PredictionHealth, creators of Sidekick, the popular AI scribe and coding assistant, ...